LOGIN
Gabapentin provides no added benefit to multimodal analgesia for total knee arthroplasty
August 2013
Gabapentin provides no added benefit to multimodal analgesia for total knee arthroplasty
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
Gabapentin does not improve multimodal analgesia outcomes for total knee arthroplasty: a randomized controlled trial
Can J Anaesth. 2013 May;60(5):423-31. doi: 10.1007/s12630-013-9902-1. Epub 2013 Mar 12.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
OE EXCLUSIVE
Dr. J. E. Paul discusses how Gabapentin provides no added benefit to multimodal analgesia for total knee arthroplasty
Synopsis
101 total knee arthroplasty patients were randomized to evaluate gabapentin’s efficacy in reducing pain and morphine consumption. They were allocated to receive gabapentin 600 mg preoperatively followed by 200 mg every eight hours for two days or to the same regimen of placebo treatment. Evaluation after the 72-hour study period demonstrated no differences between the two treatment groups in posto...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.